scispace - formally typeset
R

Roger E. Price

Researcher at Baylor College of Medicine

Publications -  109
Citations -  9254

Roger E. Price is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Lung & Prostate. The author has an hindex of 40, co-authored 108 publications receiving 8859 citations. Previous affiliations of Roger E. Price include University of Texas Health Science Center at Houston & University of Texas MD Anderson Cancer Center.

Papers
More filters
Journal ArticleDOI

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

TL;DR: In vivo studies under magnetic resonance guidance revealed that exposure to low doses of NIR light in solid tumors treated with metal nanoshells reached average maximum temperatures capable of inducing irreversible tissue damage, and found good correlation with histological findings.
Journal ArticleDOI

Elastographic characterization of HIFU-induced lesions in canine livers.

TL;DR: Elastography has the potential to become a reliable and accurate modality for HIFU therapy monitoring and a high correlation between the damaged areas as depicted by the elastograms and the corresponding areas as measured from the gross pathology photographs was found.
Journal ArticleDOI

Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

TL;DR: Certain phytochemicals, antihistamines, non-steroidal anti-inflammatory drugs and retinoids show unique preclinical promise for chemoprevention of colon cancer, with the latter two drug classes particularly effective in the post-initiation phase of carcinogenesis.
Journal ArticleDOI

Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model.

TL;DR: Postmortem histopathology of treated brain sections showed the effectiveness and selectivity of the nanoshell-assisted thermal ablation of canine transmissible venereal tumor (cTVT) in a canine brain model.
Journal Article

Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat

TL;DR: The aberrant crypt assay demonstrates reasonable specificity and sensitivity in predicting which agents are likely to prevent colon cancer, and is shown to be applicable to in vitro models of carcinogenesis.